Franco-Nevada (FNV) Forms $76.21 Double Top; Encompass Health (HLS) Had 8 Bulls

Among 15 analysts covering Healthsouth (NYSE:HLS), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. Healthsouth had 32 analyst reports since July 31, 2015 according to SRatingsIntel. Mizuho upgraded Encompass Health Corporation (NYSE:HLS) on Thursday, November 2 to “Buy” rating. The stock of Encompass Health Corporation (NYSE:HLS) has “Buy” rating given on Monday, October 9 by RBC Capital Markets. Mizuho downgraded the stock to “Neutral” rating in Wednesday, November 9 report. The stock has “Neutral” rating by Mizuho on Monday, July 10. The rating was maintained by SunTrust with “Buy” on Wednesday, December 20. The company was maintained on Thursday, October 26 by Robert W. Baird. RBC Capital Markets maintained Encompass Health Corporation (NYSE:HLS) on Wednesday, July 5 with “Buy” rating. Robert W. Baird maintained Encompass Health Corporation (NYSE:HLS) on Friday, September 1 with “Buy” rating. The company was downgraded on Monday, June 27 by Barclays Capital. The firm earned “Hold” rating on Thursday, October 29 by Stifel Nicolaus. See Encompass Health Corporation (NYSE:HLS) latest ratings:

20/12/2017 Broker: SunTrust Rating: Buy New Target: $58.0 Maintain
13/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $55.0 Maintain
02/11/2017 Broker: Mizuho Old Rating: Neutral New Rating: Buy Upgrade
26/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
26/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $56.0 Maintain
09/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $55.0 Maintain
09/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $55.0 Maintain
07/09/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
01/09/2017 Broker: Robert W. Baird Rating: Buy New Target: $51.0 Maintain
31/08/2017 Broker: Stephens Rating: Overweight New Target: $53 Initiates Coverage On

Franco-Nevada Corporation (FNV) formed double top with $80.78 target or 6.00% above today’s $76.21 share price. Franco-Nevada Corporation (FNV) has $13.76B valuation. The stock increased 0.12% or $0.09 during the last trading session, reaching $76.21. About 499,375 shares traded. Franco-Nevada Corporation (NYSE:FNV) has risen 12.51% since January 31, 2017 and is uptrending. It has underperformed by 4.19% the S&P500.

The stock increased 0.20% or $0.1 during the last trading session, reaching $49.41. About 406,041 shares traded. Encompass Health Corporation (NYSE:HLS) has risen 15.04% since January 31, 2017 and is uptrending. It has underperformed by 1.66% the S&P500.

Since August 3, 2017, it had 0 insider buys, and 1 sale for $972,875 activity. Another trade for 22,625 shares valued at $962,694 was sold by Tarr Mark J.

HealthSouth Corporation provides facility and home post-acute healthcare services in the United States. The company has market cap of $4.86 billion. The firm operates through two divisions, Inpatient Rehabilitation, and Home Health and Hospice. It has a 17.87 P/E ratio. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on both an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Investors sentiment increased to 1.57 in Q3 2017. Its up 0.17, from 1.4 in 2017Q2. It increased, as 30 investors sold Encompass Health Corporation shares while 77 reduced holdings. 44 funds opened positions while 124 raised stakes. 85.46 million shares or 0.59% less from 85.97 million shares in 2017Q2 were reported. Reilly Advsr Limited Com invested in 0% or 9 shares. Panagora Asset Management accumulated 370,665 shares or 0.07% of the stock. Raymond James Svcs Advsr Incorporated reported 0% in Encompass Health Corporation (NYSE:HLS). Financial Bank Of New York Mellon invested in 0.02% or 1.59 million shares. Mesirow Fin Management invested in 0.12% or 38,150 shares. Fny Managed Accounts Limited Liability Corp owns 20,944 shares for 1.27% of their portfolio. Alpha Windward Limited Liability Company holds 0.02% or 743 shares. Boston Private Wealth Ltd Llc has 18,837 shares for 0.03% of their portfolio. Maryland-based Clearbridge Lc has invested 0.35% in Encompass Health Corporation (NYSE:HLS). 204,565 were accumulated by Savings Bank Of Montreal Can. Amalgamated Bankshares holds 0.02% of its portfolio in Encompass Health Corporation (NYSE:HLS) for 13,540 shares. Victory Cap Mngmt Inc, Ohio-based fund reported 1.64 million shares. Schwab Charles Investment Mgmt Inc reported 785,074 shares. Aqr Cap Limited Liability Corporation owns 41,193 shares or 0% of their US portfolio. High Pointe Cap Mgmt Ltd reported 7,610 shares.

Among 17 analysts covering Franco-Nevada Corp (NYSE:FNV), 7 have Buy rating, 1 Sell and 9 Hold. Therefore 41% are positive. Franco-Nevada Corp has $96.0 highest and $47 lowest target. $71.75’s average target is -5.85% below currents $76.21 stock price. Franco-Nevada Corp had 36 analyst reports since August 11, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, December 20 by Deutsche Bank. On Thursday, February 9 the stock rating was upgraded by Goldman Sachs to “Neutral”. JP Morgan maintained it with “Neutral” rating and $56 target in Monday, March 14 report. On Thursday, October 19 the stock rating was maintained by TD Securities with “Buy”. The firm earned “Outperform” rating on Friday, January 13 by Credit Suisse. As per Thursday, October 8, the company rating was upgraded by TD Securities. As per Thursday, December 8, the company rating was upgraded by Dundee Securities. The firm has “Equal-Weight” rating by Barclays Capital given on Thursday, January 14. The firm has “Hold” rating given on Monday, August 31 by Zacks. Deutsche Bank upgraded the shares of FNV in report on Friday, September 9 to “Hold” rating.

Analysts await Franco-Nevada Corporation (NYSE:FNV) to report earnings on March, 28. They expect $0.28 earnings per share, up 16.67% or $0.04 from last year’s $0.24 per share. FNV’s profit will be $50.54M for 68.04 P/E if the $0.28 EPS becomes a reality. After $0.30 actual earnings per share reported by Franco-Nevada Corporation for the previous quarter, Wall Street now forecasts -6.67% negative EPS growth.